Skip to main content
SpringerLink
Log in
Book cover

Handbook of Nutrition, Diet, and Epigenetics pp 1845–1856Cite as

Epigenetic Drivers of Resveratrol-Induced Suppression of Mammary Carcinogenesis: Addressing miRNAs, Protein, mRNA, and DNA Methylation

  • Reference work entry
  • First Online:

  • 126 Accesses

Abstract

There are both cis- and trans-isomers of resveratrol, with the trans-isomer the more active of the two. Trans-resveratrol is present in a variety of foods, and preclinical data suggest that the agent is effective in both preventing the formation of mammary tumors and in shrinking tumors that have developed. The agent has mild to no human toxicity over a wide dose range. On the other hand, efficacy in humans has not been proven, and first-pass effects through conjugation in the liver have led people to question its clinical usefulness, although evidence of deconjugation intracellularly has also been demonstrated. The epigenetic mechanisms of action of the agent are many, including effects on miRNAs, protein, mRNA, and DNA methylation. Findings to date will be reviewed, with a look to where investigations are headed to better assess clinical efficacy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   579.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

DNA:

Deoxyribonucleic acid

miRNA:

microRNA

mRNA:

Messenger RNA

RNA:

Ribonucleic acid

References

  • Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107–116

    Article  CAS  Google Scholar 

  • Berner C, Aumuller E, Gnauck A, Nestelberger M, Just A, Haslberger AG (2010) Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57:183–189

    Article  CAS  Google Scholar 

  • Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61:7456–7463

    CAS  PubMed  Google Scholar 

  • Brown SA, Sandhu N, Herrmann J (2015) Systems biology approaches to adverse drug effects: the example of cardio-oncology. Nat Rev Clin Oncol 12:718–731

    Article  CAS  Google Scholar 

  • Cheishvili D, Boureau L, Szyf M (2015) DNA demethylation and invasive cancer: implications for therapeutics. Br J Pharmacol 172:2705–2715

    Article  CAS  Google Scholar 

  • Chen FP, Chien MH (2014) Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro. Climacteric 17:682–691

    Article  CAS  Google Scholar 

  • Colin D, Lancon A, Delmas D, Lizard G, Abrossinow J, Kahn E, Jannin B, Latruffe N (2008) Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses. Biochimie 90:1674–1684

    Article  CAS  Google Scholar 

  • Dhar S, Hicks C, Levenson AS (2011) Resveratrol and prostate cancer: promising role for microRNAs. Mol Nutr Food Res 55:1219–1229

    Article  CAS  Google Scholar 

  • Fan Y, Liu L, Fang K, Huang T, Wan L, Liu Y, Zhang S, Yan D, Li G, Gao Y, Lv Y, Chen Y, Tu Y (2016) Resveratrol ameliorates cardiac hypertrophy by down-regulation of miR-155 through activation of breast cancer type 1 susceptibility protein. J Am Heart Assoc 5:e002648

    PubMed  PubMed Central  Google Scholar 

  • Gambini J, Ingles M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, Mas-Bargues C, Abdelaziz KM, Gomez-Cabrera MC, Vina J, Borras C (2015) Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxidative Med Cell Longev 2015:837042

    Article  CAS  Google Scholar 

  • Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, Yamaguchi Y (2003) The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 10:193–202

    Article  CAS  Google Scholar 

  • Izzotti A, Cartiglia C, Steele VE, Deflora S (2012) MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat Res Rev Mutat Res 751:287–303

    Article  CAS  Google Scholar 

  • Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220

    Article  CAS  Google Scholar 

  • Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, Latruffe N (2004) Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 68:1113–1118

    Article  CAS  Google Scholar 

  • Kala R, Tollefsbol TO (2016) A novel combinatorial epigenetic therapy using resveratrol and pterostilbene for restoring estrogen receptor-alpha (ERalpha) expression in ERalpha-negative breast cancer cells. PLoS One 11:e0155057

    Article  Google Scholar 

  • Kala R, Shah HN, Martin SL, Tollefsbol TO (2015) Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent gamma-H2AX and telomerase regulation in triple-negative breast cancer. BMC Cancer 15:672

    Article  Google Scholar 

  • Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89–97

    Article  CAS  Google Scholar 

  • Lancon A, Kaminski J, Tili E, Michaille JJ, Latruffe N (2012) Control of microRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem 60:8783–8789

    Article  CAS  Google Scholar 

  • Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31:1609–1622

    Article  CAS  Google Scholar 

  • Lubecka K, Kurzava L, Flower K, Buvala H, Zhang H, Teegarden D, Camarillo I, Suderman M, Kuang S, Andrisani O, Flanagan JM, Stefanska B (2016) Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis 37:656–668

    Article  CAS  Google Scholar 

  • Malumbres M (2012) miRNAs and cancer: An epigenetics view. Mol Aspects Med 34:863–874

    Article  Google Scholar 

  • Mattiske S, Suetani RJ, Neilsen PM, Callen DF (2012) The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomark Prev 21:1236–1243

    Article  CAS  Google Scholar 

  • Mccormack D, Mcfadden D (2013) A review of pterostilbene antioxidant activity and disease modification. Oxidative Med Cell Longev 2013:575482

    Article  Google Scholar 

  • Mgbonyebi OP, Russo J, Russo IH (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12:865–869

    CAS  PubMed  Google Scholar 

  • Osman AM, Telity SA, Damanhouri ZA, Al-Harthy SE, Al-Kreathy HM, Ramadan WS, Elshal MF, Khan LM, Kamel F (2015) Chemosensitizing and nephroprotective effect of resveratrol in cisplatin -treated animals. Cancer Cell Int 15:6

    Article  Google Scholar 

  • Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392–7399

    Article  CAS  Google Scholar 

  • Qin W, Zhu W, Sauter ER (2005) Resveratrol induced DNA methylation in ER+ breast cancer. Proc Am Assoc Cancer Res 96:2750A

    Google Scholar 

  • Qin W, Zhu W, Zhang K, Clarke K, Sauter ER (2012) Resveratrol decreases tumor formation in a human relevant animal model of breast cancer. In: 11th annual conference, Frontiers of Cancer Prevention Research, A36

    Google Scholar 

  • Qin W, Zhang K, Clarke K, Weiland T, Sauter ER (2014) Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue. Nutr Cancer 66:270–277

    Article  CAS  Google Scholar 

  • Rai G, Mishra S, Suman S, Shukla Y (2016) Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: a mechanistic insight. Phytomedicine 23:233–242

    Article  CAS  Google Scholar 

  • Ronghe A, Chatterjee A, Singh B, Dandawate P, Abdalla F, Bhat NK, Padhye S, Bhat HK (2016) 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors alpha and beta in breast cancer cells. Toxicol Appl Pharmacol 301:1–13

    Article  CAS  Google Scholar 

  • Santner SJ, Feil PD, Santen RJ (1984) In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59:29–33

    Article  CAS  Google Scholar 

  • Singh B, Shoulson R, Chatterjee A, Ronghe A, Bhat NK, Dim DC, Bhat HK (2014) Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis 35:1872–1880

    Article  CAS  Google Scholar 

  • Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875–21882

    Article  CAS  Google Scholar 

  • Subbaramaiah K, Sue E, Bhardwaj P, Du B, Hudis CA, Giri D, Kopelovich L, Zhou XK, Dannenberg AJ (2013) Dietary polyphenols suppress elevated levels of proinflammatory mediators and aromatase in the mammary gland of obese mice. Cancer Prev Res (Phila) 6:886–897

    Article  CAS  Google Scholar 

  • Sun B, Hoshino J, Jermihov K, Marler L, Pezzuto JM, Mesecar AD, Cushman M (2010) Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer. Bioorg Med Chem 18:5352–5366

    Article  CAS  Google Scholar 

  • Suzuki H, Maruyama R, Yamamoto E, Kai M (2012) DNA methylation and microRNA dysregulation in cancer. Mol Oncol 6:567–578

    Article  CAS  Google Scholar 

  • Veeck J, Esteller M (2010) Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 15:5–17

    Article  Google Scholar 

  • Wang LX, Heredia A, Song H, Zhang Z, Yu B, Davis C, Redfield R (2004) Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharm Sci 93:2448–2457

    Article  CAS  Google Scholar 

  • Zhu W, Qin W, Zhang K, Rottinghaus GE, Chen YC, Kliethermes B, Sauter ER (2012) Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer 64:393–400

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hartford HealthCare Cancer Institute, Hartford, CT, USA

    E. R. Sauter

Authors
  1. E. R. Sauter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. R. Sauter .

Editor information

Editors and Affiliations

  1. School of Life Sciences, University of Westminster, London, UK

    Vinood B. Patel

  2. Diabetes and Nutritional Sciences Research Division, Faculty of Life Sciences and Medicine, King’s College London, London, UK

    Victor R. Preedy

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Sauter, E.R. (2019). Epigenetic Drivers of Resveratrol-Induced Suppression of Mammary Carcinogenesis: Addressing miRNAs, Protein, mRNA, and DNA Methylation. In: Patel, V., Preedy, V. (eds) Handbook of Nutrition, Diet, and Epigenetics. Springer, Cham. https://doi.org/10.1007/978-3-319-55530-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55530-0_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55529-4

  • Online ISBN: 978-3-319-55530-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation